|
This is an index of adverse event reports related to Atenolol. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (273)
Cases resulting in a serious event (258)
Cases resulting in death (20)
Cases resulting in life threatening events (29)
Cases resulting in hospitalization (129)
Cases resulting in disability (27)
Cases resulting in other serious reactions (109)
Below is a sample of adverse event reports reports related to Atenolol. For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 39 year old female receiving Atenolol
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31
Patient: 39 year old female, weighing 77.6 kg (170.6 pounds)
Adverse reactions / side effects: Conduction Disorder, Hypoaesthesia, Thinking Abnormal, Female Orgasmic Disorder, Sleep Disorder, Dizziness, Nervous System Disorder, Feeling Abnormal, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Adverse event in female receiving Atenolol
Reported by a physician from United States on 2007-10-30
Patient: female, weighing 57.7 kg (126.8 pounds)
Adverse reactions / side effects: Renal Failure, Dependence ON Enabling Machine or Device
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Atenolol
Truvada
Indication: HIV Infection
Start date: 2006-09-01
End date: 2007-06-01
Other drugs received by patient: Lipitor; Enalapril Maleate; Glucophage; Zocor; Wellbutrin; Glucotrol
Adverse event in 47 year old male receiving Atenolol
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-30
Patient: 47 year old male
Adverse reactions / side effects: Drug Interaction, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Amisulpride
Administration route: Oral
Atenolol
Administration route: Oral
Doxazosin Mesylate
Administration route: Oral
Fentanyl
Omeprazole
Administration route: Oral
Pantoprazole Sodium
Procyclidine Hydrochloride 2MG TAB
Administration route: Oral
Rifampicin
Zopiclone
Other drugs received by patient possibly interacting with the suspect drug:
Haloperidol
Zyvox
Indication: Staphylococcal Infection
Start date: 2004-10-17
End date: 2004-10-20
Adverse event in 44 year old receiving Atenolol
Reported by a physician from United States on 2007-10-29
Patient: 44 year old
Adverse reactions / side effects: Completed Suicide
Adverse event resulted in: death
Suspect drug(s):
Atenolol
Dosage: route reported as ingestion.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Clonazepam
Dosage: route reporetd as ingestion.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Clonidine
Dosage: route repored as ingestion.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Unspecified Drugs
Indication: Drug USE FOR Unknown Indication
Adverse event in 79 year old female receiving Atenolol
Reported by a individual with unspecified qualification from Spain on 2007-10-29
Patient: 79 year old female
Adverse reactions / side effects: Syncope, Drug Interaction, Bradycardia, Sinus Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Atenolol
Indication: Ischaemic Cardiomyopathy
Start date: 2005-01-01
End date: 2007-06-30
Diltiazem Hydrochloride
Dosage: 60 mg;
Indication: Ischaemic Cardiomyopathy
Start date: 2005-01-01
End date: 2007-06-30
Exelon
Dosage: po
Administration route: Oral
Indication: Dementia
Start date: 2007-03-30
End date: 2007-06-30
Nitro-DUR
Dosage: 120 mg;
Indication: Ischaemic Cardiomyopathy
Start date: 2005-01-01
Other drugs received by patient: Prednisone; Acetylsalicylic Acid SRT; Atorvastatin Calcium
Adverse event in 30 year old receiving Atenolol
Reported by a physician from United States on 2007-10-29
Patient: 30 year old
Adverse reactions / side effects: Completed Suicide
Adverse event resulted in: death
Suspect drug(s):
Atenolol
Dosage: route: ingestion. acute exposure.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Clonazepam
Dosage: route: ingestion. acute exposure.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Atenolol
Reported by a individual with unspecified qualification from United States on 2007-10-26
Patient: female
Adverse reactions / side effects: Malaise, Sepsis
Suspect drug(s):
Amlodipine Besylate
Indication: Hypertension
Atenolol
Indication: Hypertension
Hydrochlorothiazide
Indication: Hypertension
Adverse event in 29 year old receiving Atenolol
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: 29 year old
Adverse reactions / side effects: Drug Exposure During Pregnancy, Foetal Growth Retardation
Suspect drug(s):
Atenolol
Other drugs received by patient: Methyldopa; Methyldopa
Adverse event in 58 year old female receiving Atenolol
Reported by a physician from United States on 2007-10-22
Patient: 58 year old female
Adverse reactions / side effects: Blood Urea Increased, Blood Potassium Increased, Nodal Rhythm, Sinus Bradycardia, Syncope, Asthenia, Blood Creatinine Increased, Blood Pressure Decreased, Blood Glucose Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Dosage: 100 mg; daily;
Captopril
Dosage: 50 mg; twice a day;
Diltiazem Hydrochloride
Dosage: 360 mg; every morning; 240 mg; at bedtime;
Hydrochlorothiazde TAB
Adverse event in 69 year old male receiving Atenolol
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-22
Patient: 69 year old male
Adverse reactions / side effects: Colitis Collagenous, Colitis Ulcerative
Suspect drug(s):
Aspirin
Indication: Drug USE FOR Unknown Indication
Atenolol
Indication: Drug USE FOR Unknown Indication
Enalapril Maleate
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Tamiflu
Adverse event in 79 year old female receiving Atenolol
Reported by a individual with unspecified qualification from Spain on 2007-10-19
Patient: 79 year old female
Adverse reactions / side effects: Syncope, Cardiac Pacemaker Insertion, Drug Interaction, Bradycardia, Sinus Arrest
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Atenolol
Dosage: unk, unk
Indication: Ischaemic Cardiomyopathy
Start date: 2005-01-01
End date: 2007-06-30
Exelon
Dosage: 2 mg/ml, unk
Administration route: Oral
Indication: Dementia
Start date: 2007-03-30
End date: 2007-06-30
Masdil
Dosage: 60 mg, unk
Indication: Ischaemic Cardiomyopathy
Start date: 2005-01-01
End date: 2007-06-30
Other drugs received by patient: Prednisone; Acetylsalicylic Acid; Atorvastatin Calcium
Adverse event in 58 year old female receiving Atenolol
Reported by a physician from United States on 2007-10-18
Patient: 58 year old female
Adverse reactions / side effects: Blood Urea Increased, Blood Potassium Increased, Nodal Rhythm, Blood Creatine Increased, Syncope, Bradycardia, Blood Pressure Decreased, Asthenia, Blood Glucose Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Dosage: 100 mg; daily
Captopril
Dosage: 50 mg; twice a day
Diltiazem Hydrochloride
Dosage: 360 mg; every morning; 240 mg; at bedtime
Hydrochlorothiazide
Adverse event in 62 year old male receiving Atenolol
Reported by a physician from United States on 2007-10-18
Patient: 62 year old male
Adverse reactions / side effects: Wheezing, Hyperhidrosis, Pallor, Sinus Bradycardia, Weight Increased, Haematocrit Decreased, Crepitations, Oedema, Orthopnoea, Blood Creatinine Increased, Cold Sweat, Blood Urea Increased, Angina Pectoris, Urine Output Decreased, Blood Potassium Increased, Haemodialysis, Haemoglobin Decreased, Syncope
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Dosage: 25 mg, twice a day;
Clonidine
Dosage: 0.4 mg; weekly; transdermal
Furosemide
Dosage: 80 mg; daily;
Insulin
Irbesartan
Dosage: 150 mg, twice a day;
Metolazone
Dosage: 2.5 mg; daily;
Naproxen
Potassium Chloride
Dosage: 20 meq; daily;
Terazosin Hydrochloride
Dosage: 5 mg; daily;
Verapamil
Dosage: 360 mg, daily;
Adverse event in 74 year old male receiving Atenolol
Reported by a physician from United Kingdom on 2007-10-18
Patient: 74 year old male, weighing 65.1 kg (143.2 pounds)
Adverse reactions / side effects: Pancreatitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Dosage: beta blocker
Indication: Drug USE FOR Unknown Indication
Bevacizumab
Dosage: treatment interrupted. current cycle number 3
Indication: Colon Cancer
Start date: 2007-07-04
Bevacizumab
Start date: 2007-09-20
Capecitabine
Dosage: treatment interrupted. current cycle number 3
Administration route: Oral
Indication: Colon Cancer
Start date: 2007-07-04
Capecitabine
Administration route: Oral
Start date: 2007-09-20
Simvastatin
Dosage: lipid regulating drug
Indication: Drug USE FOR Unknown Indication
Adverse event in 73 year old female receiving Atenolol
Reported by a physician from United States on 2007-10-18
Patient: 73 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Haematocrit Decreased, Dizziness, Sinus Arrest, Blood Creatinine Increased, Lethargy, Blood Urea Increased, Cardiac Murmur, Dyspnoea, Vomiting, Nausea, Nodal Rhythm, Troponin Increased, Blood Creatine Phosphokinase MB Increased, Haemoglobin Decreased, Asthenia, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Dosage: 50 mg, daily; 25 mg, daily;
Candesartan Cilexetil
Dosage: 32 mg; daily,
Diltiazem Hydrochloride
Dosage: 120 mg; daily;
Furosemide
Isosorbide Mononitrate
Metolazone
Adverse event in male receiving Atenolol
Reported by a individual with unspecified qualification from Switzerland on 2007-10-17
Patient: male
Adverse reactions / side effects: Dyspnoea, Bronchitis, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Dosage: ;po
Administration route: Oral
Indication: Hypertension
End date: 2007-08-20
Hyzaar
Dosage: ;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
End date: 2007-08-20
Isradipine
Dosage: ;po
Administration route: Oral
Indication: Hypertension
End date: 2007-08-22
Other drugs received by patient: Atacand; Cardensiel; Amlor; Tahor; Acarbose; Glipizide; Stagid
Adverse event in 23 year old female receiving Atenolol
Reported by a consumer/non-health professional from United States on 2007-10-16
Patient: 23 year old female
Adverse reactions / side effects: Hypertension
Suspect drug(s):
Atenolol
Adverse event in 57 year old male receiving Atenolol
Reported by a physician from United States on 2007-10-16
Patient: 57 year old male
Adverse reactions / side effects: Hepatotoxicity
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Other drugs received by patient possibly interacting with the suspect drug:
Herbal Formulations
Adverse event in 68 year old male receiving Atenolol
Reported by a health professional (non-physician/pharmacist) from Australia on 2007-10-15
Patient: 68 year old male
Adverse reactions / side effects: Cardiac Failure, Interstitial Lung Disease
Adverse event resulted in: death
Suspect drug(s):
Atenolol
Candesartan Cilexetil
Esomeprazole
Furosemide
Simvastatin
Warfarin Sodium
Adverse event in female receiving Atenolol
Reported by a consumer/non-health professional from United States on 2007-10-12
Patient: female, weighing 81.6 kg (179.6 pounds)
Adverse reactions / side effects: Agitation, Anxiety, Fatigue, Visual Field Defect, Depression, Unevaluable Event, Hallucination
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Adverse event in 67 year old female receiving Atenolol
Reported by a pharmacist from United States on 2007-10-11
Patient: 67 year old female, weighing 62.1 kg (136.7 pounds)
Adverse reactions / side effects: Irritability, Blood Pressure Increased, Drug Effect Decreased, Visual Disturbance, Headache, Pharmaceutical Product Complaint
Suspect drug(s):
Atenolol
Adverse event in female receiving Atenolol
Reported by a consumer/non-health professional from United States on 2007-10-10
Patient: female
Adverse reactions / side effects: Myocardial Infarction
Suspect drug(s):
Accupril
Atenolol
Administration route: Oral
Adverse event in 39 year old male receiving Atenolol
Reported by a consumer/non-health professional from United States on 2007-10-10
Patient: 39 year old male, weighing 127.0 kg (279.4 pounds)
Adverse reactions / side effects: Weight Increased, Fatigue, Mental Status Changes, Disturbance in Attention, Depression, Depressed Mood, Decreased Interest, Suicidal Ideation
Suspect drug(s):
Atenolol
Other drugs received by patient: Lexapro; Wellbutrin XL; Cymbalta
Adverse event in male receiving Atenolol
Reported by a physician from United States on 2007-10-09
Patient: male
Adverse reactions / side effects: Syncope, Fall
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Administration route: Oral
Indication: Cardiac Failure
Start date: 1993-01-01
End date: 2006-04-07
E2020
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2004-04-27
Other drugs received by patient: Memantine HCL; Tocopherol Concentrate CAP; Psyllium Hydrophilic Mucilloid; Valsartan; Valsartan; Centrum Silver; Lotrimin; Lamisil; Colace; Claritin; Zocor; Acetylsalicylic Acid; Zyrtec; Rasagiline
Adverse event in 74 year old male receiving Atenolol
Reported by a physician from United Kingdom on 2007-10-08
Patient: 74 year old male, weighing 65.1 kg (143.2 pounds)
Adverse reactions / side effects: Pancreatitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Atenolol
Dosage: beta blocker
Indication: Drug USE FOR Unknown Indication
Bevacizumab
Dosage: treatment interrupted. current cycle number 3
Indication: Colon Cancer
Start date: 2007-07-04
Capecitabine
Dosage: treatment interrupted. current cycle number 3
Administration route: Oral
Indication: Colon Cancer
Start date: 2007-07-04
Simvastatin
Dosage: lipid regulating drug
Indication: Drug USE FOR Unknown Indication
|
